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Purpose: Previously, the authors demonstrated that the lack of the P2X7 receptor impairs epithelial wound healing and
stromal collagen organization in the cornea. The goal here is to characterize specific effects of the P2X7 receptor on
components of the corneal stroma extracellular matrix.
Methods: Unwounded corneas from P2X7 knockout mice (P2X7−/−) and C57BL/6J wild type mice (WT) were fixed and
prepared for quantitative and qualitative analysis of protein expression and localization using Real Time PCR and
immunohistochemistry. Corneas were stained also with Cuprolinic blue for electron microscopy to quantify proteoglycan
sulfation in the stroma.
Results: P2X7−/− mice showed decreased mRNA expression in the major components of the corneal stroma: collagen
types I and V and small leucine-rich proteoglycans decorin, keratocan, and lumican. In contrast P2X7−/− mice showed
increased mRNA expression in lysyl oxidase and biglycan. Additionally, we observed increases in syndecan 1, perlecan,
and type III collagen. There was a loss of perlecan along the basement membrane and enhanced expression throughout
the stroma, in contrast with the decreased localization of other proteoglycans throughout the stroma. In the absence of
lyase digestion there was a significantly smaller number of proteoglycan units per 100 nm of collagen fibrils in the
P2X7−/− compared to WT mice. While digestion was more pronounced in the WT group, double digestion with Keratanase
I and Chondroitinase ABC removed 88% of the GAG filaments in the WT, compared to 72% of those in the P2X7−/− mice,
indicating that there are more heparan sulfate proteoglycans in the latter.
Conclusions: Our results indicate that loss of P2X7 alters both the expression of proteins and the sulfation of proteoglycans
in the corneal stroma.
P2X7  is  one  of  seven  known  ion-gated  purinergic
receptors. It is naturally activated by ATP, which is released
in  injury  or  stress  conditions,  leading  to  an  increase  in
intracellular calcium. The receptor can also be activated by
BzATP, a potent synthetic agonist that is specific for the
receptor [1-3]. The P2X7 receptor plays various signaling
roles, depending on the cell type. For example, P2X7 induces
apoptosis  in  many  cells  through  lethal  increases  of
intracellular  calcium  [1,3].  In  other  cell  types,  such  as
macrophages  or  microglia,  P2X7  activates  the  mitogen-
activated protein kinase (MAP) kinase/extracellular signal-
regulated kinase (ERK)1/2 signaling pathway to promote cell
growth and proliferation [1,4,5]. In the cornea, P2X7 has been
shown  to  facilitate  wound  healing  and  epithelial  cell
migration, and regulate collagen organization in the stroma
[6].
Type I collagen, a major extracellular matrix protein of
the cornea, is synthesized as precursor molecules that undergo
post-translational modifications and are arranged into fibrillar
arrays that become cross-linked by lysyl oxidase [7-9]. Cross-
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linking  increases  the  tensile  strength  of  collagen  and  is
necessary to withstand constant stresses [7]. In the stroma,
which  constitutes  approximately  90%  of  the  cornea’s
thickness, collagen is usually organized into lamellae. The
lamellae are arranged at an angle, often nearly orthogonal to
each other [9,10]. An individual lamella consists of many
collagen fibrils arranged in parallel. In addition, fibrils are
detected inserting into Bowman’s membrane in the anterior
stroma [11]. This precise organization is extremely important
to the transparent properties of the cornea [7,10,12].
Previously, we showed that the lack of P2X7 in the cornea
affected stromal organization and expression of collagen and
associated proteins [6]. Lamellar organization changed from
a  nearly  orthogonal  arrangement  to  a  swirling  pattern.
Individual fibrils were thinner and interfibrillar spacing was
greater, leading to increased width of lamellae and separation
into layers in the mid and posterior stroma.
Collagen alignment is directly related to expression of
proteoglycans, which bind to the structures and help organize
the collagen into fibrillar arrays [9,13]. Though type I collagen
is the predominant component of the stroma, type V collagen
and specific proteoglycans are important in regulating fibril
diameter  [7,14,15].  Each  proteoglycan  comprises  a  core
protein attached to varying numbers of glycosaminoglycan
side chains, whose sulfated moieties hydrate the cornea and
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128contribute to regulation of interfibrillar spacing [9,13,16-18].
For these reasons, small leucine-rich proteoglycans (SLRPs)
are important to the transparency and refractile properties of
the  cornea.  Decorin  and  biglycan  have  one  and  two
glycosaminoglycan (GAG) side chains, respectively. Decorin
also binds type I collagen to the carboxyl termini of type XII
and  type  XIV  collagen,  members  of  the  fibril-associated
collagens  with  interrupted  triple  helices  (FACIT)  family
found in the cornea [9,19-21]. Keratocan and lumican contain
keratan sulfate side chains, and are important for maintaining
the spacing of collagen fibrils and the curvature of the cornea
[13,16,18,22]. Keratocan expression is specific to the cornea
[13,22]. Additionally, decorin prevents lateral expansion of
collagen  fibrils  and  lumican  promotes  lengthwise  growth
[13,14,17,23].
The heparan sulfate proteoglycans (HSPGs), syndecan
and  perlecan,  are  important  for  maintenance  of  corneal
integrity. Perlecan’s various functions include mediating cell
adhesion  by  binding  to  type  IV  collagen  and  laminin,
components  of  the  basement  membrane,  and  binding  to
growth factors that mediate cell migration and proliferation
[24]. Syndecan acts through α9 integrin localization in corneal
keratinocytes to mediate cell migration and proliferation in
wound closure [25].
The purpose of this study was to explain the causes of
stromal variation due to P2X7 deficiency. We investigate the
altered collagen properties in P2X7
−/− mice and examine the
role of the P2X7 receptor in maintaining corneal structure and
function.  Our  data  demonstrate  that  the  expression  and
localization of proteoglycans and related proteins are altered
in P2X7-deficient corneas, indicating a regulatory role for
P2X7 in the corneal stroma. We hypothesize that P2X7 plays
a critical role in the development and/or regenerative capacity
of the corneal stroma.
METHODS
Materials:  P2X7  null  mice  (P2X7
−/−)  strain  B6.129P2-
P2rx7tm1GaB/J and wild-type mice (WT) strain C57BL/6J were
acquired  from  Jackson  Laboratories  (Bar  Harbor,  ME)  5
weeks  postnatal  and  were  acclimated  for  16  days.  The
polyclonal antibody against keratocan was from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA), the polyclonal decorin
and lumican antibodies were purchased from R&D Systems,
Inc. (Minneapolis, MN) and the monoclonal antibody against
perlecan  was  from  Millipore  (Billerica,  MA).  SlowFade
antifade  reagent,  To-Pro  3AM,  Alexa  Fluor-conjugated
secondary  antibodies,  TRIzol  reagent,  DNasel,  Maloney
Murine Leukemia Virus reverse transcriptase (MMLV-RT),
random  hexamers,  and  RNaseH  were  purchased  from
Invitrogen (Carlsbad, CA). RNase inhibitor was purchased
from  Roche  Applied  Science  (Indianapolis,  IN).  TaqMan
Gene  Expression  Assays  were  purchased  from  Applied
Biosystems (Foster City, CA). Keratanase I, Heparinase I and
III were from Seikagaku (Tokyo, Japan), and Chondroitinase
ABC was from Sigma (St. Louis, MO). Cuprolinic blue and
other supplies for electron microscopy were purchased from
Electron  Microscopy  Sciences  (Hatfield,  PA).  Routine
chemicals  were  purchased  from  Qiagen  (Valencia,  CA),
American Bioanalytical (Natick, MA) and Fisher Scientific
(Waltham, MA).
Animals: Animals were used in accordance with international
standards for animal treatment established by the National
TABLE 1. TAQMAN® GENE EXPRESSION ASSAYS. REAL TIME PCR WAS PERFORMED USING 1 ΜL OF EACH TAQMAN® GENE EXPRESSION
ASSAYS FROM APPLIED BIOSYSTEMS (FOSTER CITY, CA) TO DETECT AND QUANTIFY THE CORRESPONDING MRNA TARGET.
Target Applied Biosystems TaqMan® Gene Expression Assay
β-actin Mm026109580_g1
Collagen α1(I) Rn00801649_g1
Collagen α1(III) Mm00802331_m1
Collagen α1(V) Mm00489842_m1
Collagen α1(XII) Mm00483425_m1
Collagen α1(XIV) Mm00805269_m1
Lysyl Oxidase Rn00566984_m1
Lysyl Oxidase Like-2 Mm00804740_m1
Lysyl Oxidase Like-3 Mm00442953_m1
Lysyl Oxidase Like-4 Mm00446385_m1
Decorin Mm00514535_m1
Keratocan Mm00515230_m1
Biglycan Mm00455918_m1
Lumican Mm01248292_m1
Perlecan Mm01181165_m1
Syndecan 1 Rn00564662_m1
Syndecan 1 Rn00564662_m1
Syndecan 4 Rn00561900_m1
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129Institutes of Health and ARVO. P2X7
−/− and WT mice were
euthanized using carbon dioxide asphyxiation and cervical
dislocation. Death was confirmed by observing the lack of a
toe-pinch  response.  For  RNA  extraction,  the  corneal
epithelium was removed from the eye using a sterile surgical
blade. The de-epithelialized corneas from four mice were
pooled and frozen at −80 °C.
Real time polymerase chain reaction (RT–PCR): Each target
was amplified from three independent pools of six stromas
each, obtained from mice of the same litter as described [6].
Experiments were performed on three independent samples
of each group. Briefly, RNA was extracted from homogenized
corneal  stromas  using  TRIzol  as  per  the  manufacturer’s
guidelines, and total RNA concentration was determined with
a spectrophotometer. RNA was incubated with DNase I and
1 U/μl RNase inhibitor to remove any contaminating genomic
DNA. Then, reverse transcription was performed with 100 U/
μl  MMLV-RT,  10  ng/μl  random  primers,  0.5  nM  dNTP
mixture, and 10 mM DTT in 10× first strand reaction buffer.
Negative control reactions were assembled without MMLV-
RT. The cDNA produced was treated with RNaseH. Real
Time PCR was performed using an ABI 7300 cycler (Applied
Biosystems, Foster City, CA). The TaqMan Eukaryotic 18S
rRNA Endogenous control assay was used in addition to the
TaqMan gene expression assays indicated in Table 1. The
cycling  parameters  were  as  follows:  an  initial  10  min
incubation at 95 °C, followed by 45 cycles of 95 °C for 15 s
and 60 °C for 1 min. The ΔΔCt method was used to determine
the relative expression of each transcript, normalized to the
18S ribosomal subunit. Comparisons to determine statistical
significance  between  WT  and  P2X7
-/-  were  made  using
Student’s t-test.
Immunohistochemistry  and  image  acquisition:  Eyes  were
enucleated,  placed  cornea  side  down  in  Optimal  Cutting
Temperature  (OCT)  media  and  flash  frozen.  Six  micron
sections  were  cut  and  the  slides  were  stored  at  −20  °C.
Experiments were performed on three independent samples
of each group.
The slides containing cryostat sections were dried at room
temperature for 1.5 h. Sections stained with anti-keratocan
were pre-digested with Keratanase I. Sections stained with
anti-perlecan  were  pre-digested  with  Heparinase  I  and
Heparinase III. Following digestion, sections were fixed in
4% paraformaldehyde for 30 min. Slides were rinsed with
PBS and blocked with 3% BSA in PBS. The slides were dried
around  the  sections  and  incubated  with  primary  antibody
diluted in 1% BSA in PBS for 1 h. Negative controls were
incubated with either 1% BSA in PBS alone or non-immune
IgG from the host animal. The slides were then rinsed 3 times
with PBS, blocked again with 3% BSA in PBS for 30 min,
and  incubated  with  Alexa  Fluor-conjugated  secondary
antibody diluted in 1% BSA in PBS for 1 h. After washing,
slides were incubated for 15 min with To-Pro 3AM diluted
1:1,000 in PBS. Slides were washed, covered with Slowfade
reagent, and coverslipped [6].
Sections were imaged using a Zeiss 200M LSM 510
confocal microscope (Zeiss, Thornwood, NY) [6,26]. The
negative control samples incubated with secondary antibody
alone were imaged first to eliminate fluorescent signal from
non-specific binding of the secondary antibody. For controls,
the detector gain and amplifier offset were set at the highest
levels possible without obtaining fluorescence, and the levels
of the detector gain and amplifier offset were maintained when
imaging experimental sections, as any signal obtained above
these levels represent specific fluorescence. Image analysis
was performed using the Zeiss Image Processing software.
Cuprolinic blue and electron microscopy: Cuprolinic blue
was used to detect sulfated proteoglycans. Four corneas from
two 9-week-old WT and P2X7
−/− mice were stained with 0.2%
Cuprolinic blue (in buffer containing 0.3 M MgCl2) for 24 h
Figure 1. P2X7−/− stromas show altered
expression  of  collagen  and  related
proteins. Real Time PCR results±SEM
of  at  least  three  independent
experiments were calculated using the
ΔΔCt  method  and  normalized  to  18S
rRNA. All sample results are presented
relative  to  the  median  WT  sample,
normalized to 1. Negative controls were
performed  without  reverse
transcriptase. * p<0.03, Student’s t-test.
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130[27]. Selective polysaccharidases were used to identify and
quantitate GAGs and proteoglycan core proteins. Enzymes
were tested for activity and specificity using highly purified
GAG standards (Seikagaku, Tokyo, Japan). Concentrations of
standards were determined before and after digestion with
specific enzymes using the dimethylene blue (DMB) assay as
described  [28,29].  Briefly,  purified  proteoglycans  were
subjected to digestion for 3 h at 37 °C in 40 mM Tris-HCl.
The pH of the digestion was adjusted to the optimum for either
Chondroitinase ABC (1.0 unit/ml, pH 8.0), or Keratanase I
(0.01 unit/ml, pH 5.9) before staining with Cuprolinic blue.
Alternatively,  the  tissue  was  digested  with  Keratanase  I
followed  by  Chondroitinase  ABC  before  staining  with
Cuprolinic  blue.  The  corneas  were  then  post-fixed  in
Karnovsky’s fixative and stained with Cuprolinic blue and
serially dehydrated before processing for TEM. Corneas were
embedded in Epon-Araldite, sectioned serially onto carbon-
coated copper grids, and stained with 4% water based uranyl
acetate. Images were taken on a Philips 300 TEM (Eindhoven,
The Netherlands). The number and periodicity of Cuprolinic-
positive  filaments  were  determined  using  NIH  ImageJ
software. Results were averaged and expressed as ± standard
error of the mean (SEM) and one-way ANOVA followed by
Tukey’s post-hoc test was performed.
RESULTS
Expression of collagen and associated protein transcripts in
P2X7
−/−  stromas:  We  studied  the  composition  of  corneal
stromas in WT and P2X7
−/− mice using RT–PCR to detect
transcripts  of  collagen,  lysyl  oxidase  (LOX),  and  lysyl
oxidase-like proteins (LOXl). There was a significant decrease
in  the  two  most  highly  expressed  stromal  collagen  types,
collagen  α1(I)  and  collagen  α3(V),  in  P2X7
−/−  mice  when
compared with WT (p≤0.05). Expression of collagen α1(III),
which is a marker of the wounded cornea and corneal scarring
and is not usually detected in the unwounded stroma, was
significantly  increased  in  P2X7
−/−  mice  compared  to  WT
(p≤0.05) (Figure 1). There was no significant difference in
expression of collagen α1(XII) or collagen α1(XIV), members
of the FACIT collagen family (Figure 1).
Expression of LOX and related LOXl was examined to
determine if alteration in transcript levels contribute to smaller
collagen fibril diameters in P2X7
−/− mouse stromas [6]. Lysyl
oxidase  expression  in  P2X7
−/−  stromas  was  significantly
greater  than  in  WT  stromas  (Figure  1).  While  LOXl3
expression in P2X7
−/− stromas was less than in WT stromas,
there  was  no  difference  in  LOXl2  and  LOXl4  expression.
Neither sample expressed detectable amounts of LOXl1.
Expression of stromal proteoglycan transcripts in P2X7
−/−
mice:  The expression of proteoglycans was studied in P2X7
−/
 corneas to  determine  potential  causes of altered collagen
lamellae  organization  in  the  stroma.  Using  RT–PCR,  we
determined  the  relative  expression  of  proteoglycan  core
proteins: keratocan, decorin, lumican, biglycan, syndecans 1
and 4, and perlecan. Relative expression of β-actin (Actb)
mRNA was unchanged between WT and P2X7
−/− mice.
There were reductions in the expression of 3 out of 4 small
leucine-rich  proteoglycans  (SLRPs)  in  P2X7
−/−  stromas
(Figure 2). Relative expression of keratocan decreased from
1.4 in WT to 0.41 in P2X7
−/− and decorin decreased from 0.99
to 0.38 (p≤0.05). The expression of lumican decreased in
P2X7
−/−, from 1.02 in WT to 0.39 in the knockout but the
difference was not significant according to Student’s t-test
(p=0.07). Compared to decorin, the expression of biglycan
was higher in the P2X7
−/− stromas, where relative expression
was 2.8 compared to 0.96 in WT stromas (p≤0.05; Figure 2).
This may be the result of a compensatory mechanism due to
Figure  2.  Altered  expression  of
proteoglycan  core  proteins  in  P2X7−/−
stromas. Real Time PCR results±SEM
of  at  least  three  independent
experiments were calculated using the
ΔΔCt  method  and  normalized  to  18S
rRNA. All sample results are presented
relative  to  the  median  WT  sample,
normalized to 1. Negative controls were
performed  without  reverse
transcriptase. * p<0.05, Student’s t-test.
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−the  decreased  expression  in  decorin,  as  was  previously
reported in decorin null mice [9,12,13].
Perlecan  has  been  found  in  low  levels  in  the  normal
stroma  and  is  increased  upon  injury  [18,30,31].  In  the
unwounded P2X7
−/− stroma, both syndecan 1 and perlecan
demonstrated  increased  expression  compared  to  the  WT
(Figure 2). As expected, there was no difference in expression
of syndecan 4. These data, along with the results showing
decreased expression of decorin and keratocan, suggest that
the lack of P2X7 holds the cornea in a pseudo-wounded state,
as syndecan 1 and perlecan are markers of corneal wounding
and scarring.
Changes in localization of keratan sulfate proteoglycans and
decorin:  We  examined  proteoglycan  localization  using
immunohistochemistry. Lumican was detected in a similar
expression pattern in both P2X7
−/− and WT stromas, apparently
aligned along the longitudinal arrays of collagen. However,
there were large areas that lacked lumican expression in the
P2X7
−/− stromas, which were not observed in the WT stromas
(Figure 3). Additionally, in the P2X7
−/− stromas the lumican
was more intense in the posterior region than the anterior and
middle regions. While there was only minimal detection of
keratocan in the WT (Figure 3, inset), it was not detectable in
the  P2X7
−/−  stromas,  consistent  with  decreased  keratocan
mRNA expression in P2X7
−/− stromas (Figure 2).
The  localization  of  decorin  was  similar  in  WT  and
P2X7
−/− stromas. However, the staining was reduced in the
P2X7
−/− and large spaces lacking the presence of detectable
decorin were observed only in the knockout tissue (Figure 4).
This overall decrease in decorin protein correlated with the
decrease in decorin mRNA (Figure 2).
Changes  in  glycosaminoglycan  sulfation  along  collagen
fibrils: Cuprolinic blue staining in the presence or absence of
lyase digestion and electron microscopy were performed to
quantify the sulfated GAG moieties associated with collagen
filaments. The sulfated GAGs are depicted as electron dense
filaments  [6,32,33].  Images  of  three  regionally  distinct
populations of collagen fibrils were taken in the presence or
absence of lyases (Figure 5). In the undigested sections, there
were a smaller number of proteoglycan units per 100 nm of
collagen fibril in the P2X7
−/− when compared to WT (Figure
6A), indicating a decrease in proteoglycan sulfation. While
the distribution of sulfated GAGs throughout the WT stroma
was homogeneous, there was a higher density of electron
dense filaments or sulfated GAGs observed in the anterior
Figure 3. KSPG localization is altered in P2X7−/− stromas. Frozen corneas were sectioned and stained with antibodies specific for keratocan
and lumican, followed by FITC-conjugated IgG (green) and counterstained with To-Pro 3AM for nuclei (blue). Negative controls were
incubated with secondary antibody only and counterstained with To-Pro 3AM. Images are representative of three independent experiments.
Keratocan (inset): enlarged regions from central stroma with enhanced signal to show detail of localization. Scale bar: 10 μm.
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−/−  corneas  than  the  middle  or  posterior
portions.
To determine the relative presence of glycosaminoglycan
subtypes, samples were digested with Keratanase I and/or
Chondroitinase ABC. Keratanase I reduced the number of
filaments per 100 nm collagen fibril by 35% in the WT, but
only  by  25%  in  the  P2X7
−/−  stromas  in  comparison  to
undigested (Figure 6A,B). Furthermore, Chondroitinase ABC
digested 74% of the filaments in WT, but only 55% of those
in  the  P2X7
−/−  group  in  comparison  to  undigested  (Figure
6A,C). The digestion of KSPGs by Keratanase I showed equal
distribution throughout the stroma of undigested filaments
throughout  both  WT  and  P2X7
−/−  corneas  (Figure  6B).  In
contrast, digestion of SLRPs by Chondroitinase ABC revealed
that the anterior portion of both WT and P2X7
−/− stromas was
composed  of  a  significantly  higher  concentration  of
chondroitin sulfate moieties than the posterior stroma (Figure
6C). When the tissue was digested with both Keratanase I and
Chondroitinase  ABC,  88%  of  the  GAG  filaments  were
removed  in  the  WT,  as  opposed  to  72%  of  those  in  the
P2X7
−/−  (Figure  6C).  These  results  may  indicate  that  the
baseline level of Chondroitinase-undigested proteoglycans, or
KSPGs and HSPGs, are reciprocally regulated in WT and
P2X7
−/−.
Changes in localization of heparan sulfate proteoglycans: As
described previously, perlecan has been detected in low levels
in the intact stroma, but is increased with injury [18,30,31]. In
the  P2X7
−/−  mouse,  perlecan  was  localized  throughout  the
stroma with the most intense staining in the posterior region
(Figure 7A, and inset). The staining was more extensive than
that detected in the WT. The increase is consistent with the
increased  perlecan  mRNA  expression  in  P2X7
−/−  stromas
(Figure 2). In addition, in the WT perlecan is present along
the  basement  membrane  of  the  corneal  epithelium,  as
reported, where it is hypothesized to play a role in epithelial
adhesion [24,34]. However, this typical staining pattern of
expression along the basal lamina and Descemet’s membrane
was absent in the P2X7
−/− corneas (Figure 7B). These indicate
that the regulation is altered.
Based  on  our  results,  the  schematic  in  Figure  8
summarizes  the  morphological  differences  in  the  P2X7
−/−
cornea  (Figure  8).  In  summary,  we  found  that  the  P2X7
receptor  regulates  corneal  stromal  composition  and
organization  at  the  transcriptional  level  of  collagen,  lysyl
oxidase,  and  proteoglycan  expression.  In  addition,  this
ionotropic receptor contributes to the proper structure and
function of the cornea. In the absence of P2X7, collagen fibrils
are thinner and more sparsely distributed, lacking the parallel
fibril organization in perpendicular lamellar sheets. There are
fewer  SLRPs  in  P2X7
−/−  stromas,  and  perlecan  protein  is
present in P2X7
−/− but lacking in WT stromas.
DISCUSSION
These studies are the first to demonstrate that the ionotropic
P2X7  receptor  alters  the  expression  and  localization  of
proteoglycans in the corneal stroma. Previously, we showed
that  changes  in  regulation  of  collagen  and  proteoglycan
expression in P2X7
−/− mice resulted in small fibril diameter,
increased interfibrillar space and lamellar width, and overall
decreased organization of collagen in the stroma [6]. The
decrease  in  collagen  α1(I)  and  collagen  α3(V)  mRNA
correlates with the findings of decreased bone formation in
P2X7
−/− mice [35]. Furthermore, perlecan has been implicated
in long bone growth [34] and its expression was altered in the
P2X7
−/−  stroma.  However,  there  is  no  known  physical
association of perlecan and collagen. Further studies may
show links between P2X7, collagen deposition, and the role of
perlecan in this process.
Figure 4. Decorin localization is altered in P2X7−/− stromas. Frozen corneas were sectioned and stained with antibody against decorin, FITC-
conjugated IgG, and To-Pro 3AM. Negative controls were incubated with non-immune IgG instead of primary antibody, and To-Pro 3AM.
Images are representative of three independent experiments. E=Epithelium, S=Stroma. Scale bar: 50 μm.
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133Figure 5. Electron micrographs of electron dense filaments stained with Cuprolinic blue on stromal collagen. Samples of A: WT and B:
P2X7−/− corneas were digested with either Keratanase I, Chondroitinase ABC, or both, before Cuprolinic blue staining and imaging with TEM.
Undigested and stained tissue are included. The scale bar seen in the undigested column represents 500 nm, and applies to all images in the
Undigested, Keratanase I, and Chondroitinase ABC columns. The scale bar seen in the Keratanase I and Chondroitinase ABC columns represent
200 nm and applies to images in that column only. Descemet’s membrane is marked with “D” and is visible in the WT posterior images.
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LOX mRNA transcript. Increased LOX activity is associated
with  decreased  collagen  fibril  diameter  and  irregular
arrangements of collagen in diabetic mice, where high glucose
levels  cause  overexpression  of  LOX.  This  overexpression
compromises the integrity of the extracellular matrix of the
retina [8]. These data may explain our observation that LOX
is significantly enhanced in P2X7
−/− stromas. Lysyl oxidase
activity  has  a  second  function  where  it  is  regulated  by
hypoxia-inducible factors. It is in this function where LOX is
enhanced in hypoxic tumors, promoting signaling through
focal adhesion kinase, and thus contributing to the invasive
properties of hypoxic cancer cells [36]. Future research may
link these factors with a role in cell migration and wound
healing.
Together,  these  data  support  our  hypothesis  that  the
downregulation of the P2X7 receptor “holds” the cornea in a
pseudo-wounded state. Injury causes release of ligands such
as transforming growth factor β (TGF-β) whose upregulation,
in turn, increases the activity of LOX to expedite crosslinking
of extracellular matrix components for wound healing [36,
37]. Furthermore, the increased presence of type III collagen
mRNA and the HSPGs syndecan 1 and perlecan mRNA in the
P2X7
−/− corneal stroma is typical of the wounded phenotype
[18,33,38]. This expression is often seen in stromal scars
where  type  III  collagen  deposition  and  perlecan
overexpression occur along with downregulation of SLRPs
[33,38,39]. Perlecan, as previously mentioned, is found along
the  basement  membranes  of  epithelium  and  endothelium
[24,34]. Not only was this localization of perlecan lacking in
P2X7
−/− corneas, but also expression of perlecan was enhanced
throughout  the  posterior  stroma,  also  indicative  of  injury
[18,30,31]. Syndecan is important for keratinocyte activation,
and syndecan-deficient mice have difficulty in wound healing
and  re-epithelialization  after  injury  [25].  We  observed
increases  in  syndecan  1,  perlecan,  and  type  III  collagen
mRNA  in  unwounded  P2X7
−/−  corneal  stromas.  Taken
together, these factors indicate that the lack of P2X7 maintains
the cornea in a pseudo-wounded state.
The  role  of  the  P2X7  receptor  in  expression  and
localization of perlecan provides more detail into alterations
that can occur at the interface of the corneal epithelium and
basal lamina. The lack of perlecan in the basement membrane
zone may contribute to the fragility of the tissue that was
Figure 6. Sulfation of glycosaminoglycans in WT and P2X7−/− corneal stromas. Collagen fibril length was measured, and the number of
proteoglycan (PG) units along that length was counted for each non-overlapping region (Anterior, Middle, Posterior) and summed for the
entire cornea (Overall). Results were normalized to number of PG units per 100 nm collagen for A: Undigested corneas, B: Corneas digested
with Keratanase I, C: Corneas digested with Chondroitinase ABC, and D: Corneas digested with both Keratanase I and Chondroitinase ABC.
A minimum of 75 measurements were performed for each region of each group and digestion condition, and results were averaged and
presented as ±SEM ** p<0.0001 and * p<0.05, one-way ANOVA followed by Tukey’s post-hoc test.
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135observed, however the fragility is not due to a decrease in the
number of hemidesmosomes compared to WT [6]. Previous
experiments  showed  separation  in  the  anterior  stroma  in
wounded P2X7
−/− corneas, rather than at the basal lamina, and
we speculated that this was due to loose collagen fibrils in the
anterior  stroma.  Observations  made  by  second  harmonic
imaging  show  collagen  fibrils  inserting  into  Bowman’s
membrane  in  normal  corneas,  which  were  absent  in
keratoconic mice [40]. Perhaps the change in matrix synthesis
has  altered  mechanical  constraints  and  fibrils  are  less
organized anteriorly. The absence of perlecan at the basement
membrane  may  have  a  larger  effect  on  the  collagen
organization underneath the basement membrane than on the
adhesion between the epithelium and the stroma, implying
that there are other adhesive proteins at work at the basement
membrane that may attach to loose collagen fibrils, pulling
them with the epithelium during wounding.
The observed increase in biglycan mRNA transcripts was
expected because of the observed decrease in decorin mRNA
transcripts.  Decorin  knockout  mice  have  shown  a
Figure 7. Perlecan localization is altered in P2X7−/− stromas. Frozen corneas were sectioned and stained with antibody against perlecan, FITC-
conjugated IgG, and To-Pro 3AM. Negative controls were incubated with non-immune IgG instead of primary antibody, and To-Pro 3AM.
Images are representative of three independent experiments. A: Perlecan expression is increased throughout the stroma in P2X7−/− corneas.
Inset: enlarged regions from the central stroma with enhanced signal to show detail of localization. Scale bar: 10 μm. B: Perlecan is localized
to the basement membrane in WT corneas (arrow) but not in P2X7−/− corneas. Scale bar: 500 μm.
Figure   8.    Schematic   of   WT   and 
P2X7−/−   corneal stromas. Rods represent
collagen fibrils, small circles represent
SLRPs,  and  rectangles  represent
perlecan.
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136compensatory upregulation of biglycan, but the reverse was
not observed in biglycan null mice [12,23]. Macroscopically,
P2X7
−/−  mice  had  no  observable  opacity  [6],  so  the
coordination  between  decorin  and  biglycan  in  collagen
regulation may contribute to some maintenance of corneal
transparency  and  function  in  P2X7
−/−  mice.  In  contrast,
previous  experiments  have  shown  decreases  in  keratocan
expression in lumican null mice, implying that lumican plays
a  regulatory  role  for  keratocan  expression  [41].  The
compensatory mechanism observed in decorin null mice for
biglycan is not observed in lumican null mice for keratocan,
as shown in the P2X7
−/− mice. The role of these proteoglycans
in corneal transparency is evident in the lumican knockout
mice’s  profoundly  opaque  corneas  and  altered  collagen
fibrillogenesis [16,17,41]. It is important to note that P2X7
−/−
mice showed decreased levels of proteoglycans, rather than a
complete  lack  of  these  proteoglycans,  so  the  general
transparency  of  P2X7
−/−  corneas  implies  that  proteoglycan
expression is graded proportional to its function in organizing
collagen in the stroma.
We conclude that the deficiency of P2X7 alters protein
expression in the corneal stroma generating a morphology
analogous  to  that  seen  in  a  wounded  phenotype.  P2X7
regulation at the transcriptional level of not only collagen
itself, but also of proteins that aid in its organization in the
corneal  stroma,  ultimately  results  in  the  altered  stromal
architecture seen in P2X7
−/− corneas.
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